Representative Zhang Boli: The moment of the epidemic, inspiring deep internal force of Chinese medicine

Our reporter Cao Xiuying and Yang Zhaohui

Discussing the plan, inspecting the ward, coordinating resources ... In the two months since the third day of the first year of the university's trip to Wuhan with the Central Guidance Group, the 72-year-old National People's Congress representative, expert from the Central Guidance Group and academician of the Chinese Academy of Engineering Zhang Boli has been busy day and night.

After fatigue caused by cholecystitis, he signed the operation himself and said with a smile, "Leave the gallbladder in Wuhan, which is more like the liver and gallbladder in Wuhan." After the cholecystitis, blood clots appeared in the legs. Definitely obedient, but only up to a week ", to return to the" front line "as soon as possible to command the battle, do not want to shake the army; considering his physical condition, the central leadership group and the relevant leaders of the State Administration of Traditional Chinese Medicine have asked him to return to Tianjin for recuperation, He rarely did not obey the organizational arrangements, "when it is needed, how can I leave, and physical difficulties can be overcome".

Retrograde and perseverance are only due to the benevolence of the healer and the feelings of his country. "There are three things that scholars can't avoid when they're alive: they can't avoid asking for their country, they can't avoid going for their country, and they can't avoid it when they are in danger." This was Zhang Boli's aspirations when he went to Wuhan.

Jiang Xia's cabin attempt

The hardest part is the beginning.

"The scene we saw when we first arrived in Wuhan was really confusing. There was a long queue of fever clinics, and the hospital was overcrowded. The diagnosed patients, suspected patients, close contacts, and escorts were all mixed up, and for a moment I didn't know where to start." Chamberlain frankly Chen.

The central steering group made timely decisions, implemented centralized isolation and classified management according to the opinions of experts. At this time, Zhang Boli and other TCM experts tried to make all the patients in centralized isolation take Chinese medicine.

Not without questioning. Can Chinese medicine play a role in this public health emergency, or is it just a placebo? Zhang Boli decided to speak with facts. He and Liu Qingquan, a member of the expert group of the Central Steering Group and the director of Beijing Traditional Chinese Medicine Hospital, wrote a letter of request and proposed that Chinese medicine enter the square cabin, and the Chinese medicine team stationed in the square cabin hospital.

After the Central Steering Group agreed, Zhang Boli and others formed a TCM medical team with 209 TCM specialists from Tianjin, Jiangsu, Henan, Hunan, and Shaanxi. They were stationed in Jiangxia Fangcai Hospital, which mainly used comprehensive Chinese medicine treatment. Here, Zhang Boli and others determined the overall treatment plan, that is, for the majority of patients in the cabin, the agreed Tongzhi formula based on the Qingfei Paidu decoction and Xuanfei Baidu formula was supplemented with Taiji, Baduanjin and acupoint stickers. Application of comprehensive treatment and rehabilitation measures.

"It also had different voices at that time. Many people said that traditional Chinese medicine is about dialectical treatment. How do you give everyone the same medicine? This is the charm of traditional Chinese medicine. Traditional Chinese medicine is not static." Zhang Boli said that the causes and symptoms of patients with new coronary pneumonia It is similar, so it is feasible to adopt the Tongzhi formula. In addition, it is difficult to implement the one-person-one strategy in the face of tens of thousands of patients.

The data proves the decision-making of TCM experts.

There were 564 patients with mild neonatal pneumonia and general patients treated during the 26-day operation of Jiangxia Fangfang Hospital, and none of them changed from mild to severe. According to the World Health Organization, about 6% to 10 of patients with neocoronary pneumonia are mild. % Changed to severe. "The more significant evidence is that blood biochemical indicators such as the number of lymphocytes and white blood cells of discharged patients have improved significantly." Zhang Boli said.

The exploration of Jiangxia's cabin cabin quickly spread to other cabin cabins. In the square cabin hospital in Wuhan, the usage rate of traditional Chinese medicine exceeds 90%. The outstanding performance of traditional Chinese medicine has become an important part of the "China Plan" for the treatment of new coronary pneumonia.

Scientific research and clinical treatment

In addition to clinical treatment, Zhang Boli has also been struggling in the field of scientific research. In the process of clinical treatment of traditional Chinese medicine, the research work under his guidance is also accelerating, and has become a supporting force to support clinical treatment decisions.

Zhang Boli was responsible for the "National Scientific and Technological Emergency Response Project-Clinical Research on Integrated Prevention of New Coronavirus Infected Pneumonia" launched on February 3. After arriving in Wuhan, he went deep into the Red Zone to check the condition, and the first task was to conduct a syndrome investigation. In order to improve the coverage of investigations and timeliness of data acquisition, while taking into account the actual conditions of clinical treatment, the research team developed a clinical data acquisition and analysis system for new coronary pneumonia. The key data collection was achieved through the mobile phone terminal's reporting and image uploading. Timeliness enables data acquisition and analysis to be carried out as early as possible.

Based on the analysis of TCM syndrome information of 1,000 patients with different disease grades from nearly 20 hospitals across the country, the syndrome characteristics and evolution of the disease were obtained. TCM experts judged that the new coronary pneumonia was a "wet poison epidemic", which is a syndrome differentiation treatment. Pointed out. On this basis, Zhang Boli directed the team to conduct research on clinical efficacy evaluation of traditional Chinese medicine, as well as drug screening and new drug development.

Carry forward the footsteps of Chinese medicine

Provincial aid medical teams have been withdrawn from Wuhan one after another, but Zhang Boli still has no date to settle. "The daybreak of dawn is clear, dawn dawns Wan Xiahong. The war demon warrior must be patient, and the triumphal class master is clear." This "Break of Dawn" is the voice of Zhang Boli.

It is conceivable that even the triumphant class teacher, the busy pace of the elderly will not stop.

After Jiangxia Fangcai Hospital was suspended, Zhang Boli's focus shifted to the rehabilitation of discharged patients. "Many critically ill patients still have symptoms of palpitations and fatigue after being discharged from hospital, and some patients' lung function and organ function are damaged. We must first evaluate and recover the symptoms."

On March 24, Zhang Boli, the national rehabilitation management platform for infected medical personnel, was officially launched. "This is a platform supported by the Chinese Academy of Engineering and the Tencent Foundation. It is specifically responsible for Wuhan Xiehe Hospital and Wuhan Traditional Chinese Medicine Hospital. We strive to take two to three years to fully recover these medical staff and return to the normal working life track. "Zhang Boli said.

He is also anxious about outbreaks abroad. "We see the situation in some European and American countries," Zhang Boli said. He has been contacted by many foreign units and organizations and asked him to introduce China's anti-epidemic experience, especially the application of Chinese medicine. "We give some countries The local climatic characteristics and situation have prepared prescriptions and sent some traditional Chinese medicine. "